Figure 6.
Resources for managing toxicities. Proportion of patients requiring steroids (A), tocilizumab (B), anakinra (C), or admission to ICU (D). Of note, data on ICU admission were missing for 20 patients. Comparisons were performed using Pearson χ2 test. ICU, intensive care unit.